Katherine Lelli
About Katherine Lelli
Katherine Lelli is the Director of US Access Marketing for Oncology at Bristol Myers Squibb, with extensive experience in market research, pricing strategies, and consulting within the oncology sector.
Company
Katherine Lelli is currently working at Bristol Myers Squibb. She holds the position of Director US Access Marketing: Oncology. Her work primarily focuses on developing strategic initiatives that aim to improve oncology patient access to innovative therapies.
Title
Katherine Lelli serves as the Director US Access Marketing: Oncology at Bristol Myers Squibb. She also holds the role of Senior Product Manager in Oncology Payer Marketing Pipeline, Portfolio Strategy & Oncology Thoracic Tumors within the same company.
Education and Expertise
Katherine Lelli earned a PhD in Genetics and Development from Columbia University in the City of New York, where she studied from 2006 to 2012. Prior to that, she completed a Bachelor of Science in Molecular Genetics and a Bachelor of Arts in German at the University of Rochester from 2002 to 2006. Her educational background has provided her with a solid foundation in genetics and molecular biology.
Background
Katherine Lelli has accumulated extensive experience in the field of oncology market access and pricing. She has held various positions at Bristol Myers Squibb, Insight Strategy Advisors, and Memorial Sloan-Kettering Cancer Center. Her roles have ranged from consulting to market research and from value propositions development to strategic planning for pharmaceutical products.
Achievements
Katherine Lelli has been instrumental in the launch of multiple oncology products at Bristol Myers Squibb, focusing on payer marketing and portfolio strategy. She has also led the development of value propositions aimed at enhancing market access and reimbursement strategies for oncology therapies. Her extensive experience in market research and pricing strategies has significantly contributed to improving patient access to innovative treatments.